RadianceTx Radionuclide Brachytherapy Source
Source, Brachytherapy, Radionuclide. 510(k) K223465, from Radiance Therapeutics, Inc. (Tucson, AZ). Product code KXK, class 2.
As of Nov 18, 2026, K223465 is an FDA 510(k) held by Radiance Therapeutics, Inc., substantially equivalent on Jan 11, 2023 after 55 days, with no recalls tied to it in FDA's recall database.
- Review time: 55 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe RadianceTx Radionuclide Brachytherapy Source (RTx-RBS) is indicated for episcleral brachytherapy of tumors and benign growths. The RTx-RBS is intended for use within a compatible manual brachytherapy applicator system.
Other KXK clearances
The newest 510(k)s for the same product code; their median review was 166 days; see every KXK deviceRecord
- Type
- Traditional
- Received
- Nov 17, 2022
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files